EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Post‐Botulinum Headache in Cosmetic Practice: A Prospective Study

Ümit Akpınar iD, Omer Vural iD, Ekrem Civas iD, Alper Koycu iD

Journal of Cosmetic Dermatology · 2026

DOI: 10.1111/jocd.70731 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2026. Verfasst von Ümit Akpınar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Private Dermatology Practice, Ankara, Türkiye. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Headache, Cosmetic Techniques, Neuromuscular Agents. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Botulinum toxin is widely used for aesthetic and functional indications and is generally considered safe; however, post‐procedural headache remains a recognized but underexplored adverse effect, particularly in cosmetic practice.

Objective

To evaluate the incidence, characteristics, and potential risk factors of headache following botulinum toxin injections administered to different anatomical regions.

Methods

This prospective observational study included 102 adult patients undergoing abobotulinumtoxinA injections to the upper facial regions, masseter muscles, and/or axillary area. Headache occurrence was assessed on day 3 by telephone, at days 10–12 during follow‐up visits, and through patient‐initiated contact within the first month. Demographic variables, prior botulinum toxin exposure, injection‐related pain, toxin dose, and headache characteristics were recorded.

Results

Post‐botulinum headache occurred in 13 patients (12.7%) and was generally mild‐to‐moderate, short‐lived, and self‐limited. Headache was significantly more frequent in first‐time recipients compared with previously treated patients (45.5% vs. 8.8%, p = 0.005). All patients who developed headache had received injections involving the upper facial regions, whereas no headache was observed after exclusive masseter or axillary treatments. No associations were found with toxin dose, procedural pain, or systemic comorbidities.

Conclusion

Post‐botulinum headache is an infrequent, benign, and transient event, predominantly affecting first‐time patients undergoing upper facial injections. These findings may aid clinicians in patient counseling and expectation management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AHeadacheCosmetic TechniquesNeuromuscular AgentsHumansProspective StudiesFemaleAdultMiddle AgedMaleInjections, IntramuscularIncidenceRisk FactorsYoung AdultMasseter Muscle

Substanzen

Botulinum Toxins, Type AabobotulinumtoxinANeuromuscular Agents

Autor:innen und Institutionen

  • Private Dermatology Practice, Ankara, Türkiye.
  • Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Kafkas University, Kars, Türkiye.
  • Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Baskent University, Ankara, Türkiye.

ORCID-Profile: Ümit Akpınar, Omer Vural, Ekrem Civas, Alper Koycu

Zitieren

APA

Akpınar, Ü., Vural, O., Civas, E., & Koycu, A. (2026). Post‐Botulinum Headache in Cosmetic Practice: A Prospective Study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70731

Vancouver

Akpınar Ü, Vural O, Civas E, Koycu A. Post‐Botulinum Headache in Cosmetic Practice: A Prospective Study. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70731

BibTeX
@article{Akpnar2026,
  author = {Akpınar, Ümit and Vural, Omer and Civas, Ekrem and Koycu, Alper},
  title = {Post‐Botulinum Headache in Cosmetic Practice: A Prospective Study},
  journal = {Journal of Cosmetic Dermatology},
  year = {2026},
  doi = {10.1111/jocd.70731}
}
Kostenlos starten →